IL17A and psoriasis: In individuals with psoriasis, DCs are major sources of IL‐23, IL‐12, and TNF‐α and activate Th17/Th1 cells to produce IL‐17 and IL‐22, which drive keratinocyte hyperproliferation and chronic inflammation [393].